Human-Relevant Models and Spatial Profiling
Why It Matters
Translating Human-Relevant Models to Clinical Success
Human-relevant models and spatial profiling are transforming drug discovery by providing more predictive, human-like data compared to traditional animal models and 2D cultures. Human-relevant models, such as organoids and 3D cell cultures, better mimic human biology, improving disease modeling, drug screening and precision medicine.
Spatial profiling further enhances these insights by mapping cellular interactions and biomarker distribution, aiding in personalized treatments for cancer, neurodegenerative diseases and autoimmune disorders. These technologies reduce reliance on animal testing, aligning with regulatory shifts and improving early toxicity assessments. By bridging the gap between preclinical research and clinical trials, human-relevant models and spatial profiling accelerate drug development, ensuring safer, more effective treatments reach patients faster.
The Life Sciences companies of Danaher provide integrated solutions for human-relevant models and spatial profiling, addressing the need for more predictive models in drug discovery. With advanced imaging, automation and AI-driven analysis, we enhance data accuracy, optimize drug response insights and drive the next generation of precision medicine.
Automation & Standardization
Automation and standardization enhance drug discovery by improving reproducibility, efficiency and reliability in human-relevant models like organoids and 3D cultures.
Expertise
We specialize in cultivating and analyzing microphysiological systems, like organoids, to enhance research integrity and accuracy for better decision-making.
Mechanisms to Report on Drug Response
Understanding drug response is crucial to all drug discovery and development programs, as miscalculations can lead to failed clinical trials and patient harm.
Decision Making with Real-Time Data
Quick access to insights demands tools for real-time analysis, data consolidation, reduced analysis time and faster insights delivery.